MedPath

Vestibular Disorder and Visuo-spatial Functions

Not Applicable
Completed
Conditions
Vestibular Diseases
Vertigo
Interventions
Behavioral: Cognitive and neuropsychological assesment
Registration Number
NCT02533739
Lead Sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Brief Summary

The purpose of these studies is to determine whether vestibular disorders could affect visuo-spatial cognition. Visuo-spatial cognition will be evaluated using a new questionnaire and a new computerized test using a digital tablet in different studies.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
94
Inclusion Criteria
  • Vestibular disorder (with or without vertigo)
  • Deafness / hard of hearing
Exclusion Criteria
  • Neurological or psychiatric conditions
  • Cochlear Implant (for functional magnetic resonance imaging study)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Control groupCognitive and neuropsychological assesmentThis group will consist of participants without vestibular/vertigo impairments.
Patient groupCognitive and neuropsychological assesmentThis group will consist of vestibular patients and/or participants with vertigo.
Primary Outcome Measures
NameTimeMethod
Vestibular questionnaire (Newly developed to evaluate cognitive abilities)Within one week after recruitment

Participants will be recruited and tested within one week of recruitment. Testing will be online and will take around 20 minutes on average. The new questionnaire will evaluate demographic questions, and different cognition abilities using a likert-scale.

Standard computerized cognitive assessment (For example : Test of attentional performance, digit span, visuo-spatial span, line bisection task,...)Within one week after recruitment

Participants will be recruited and tested within one week of recruitment. Testing will be at the hospital and will take 2 hours maximum. Standard computerized cognitive assessment will be used such as the Test of attentional performance (TAP2.2), digit span, visuo-spatial span, line bisection task, etc. Reaction times, errors and omissions will be recorded.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Cliniques universitaires Saint-Luc-UCL

🇧🇪

Bruxelles, Belgium

© Copyright 2025. All Rights Reserved by MedPath